Two pharma companies admit to price-fixing collusion
Two pharma companies in the UK have admitted to sharing “commercially sensitive” information about their drugs to help keep prices high. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 24, 2019 Category: Pharmaceuticals Source Type: news
Novo Nordisk diabetes pill gets FDA OK
The FDA gave Novo Nordisk the go-ahead for a once-daily pill to treat diabetes. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 24, 2019 Category: Pharmaceuticals Source Type: news
7 of the biggest pharma bankruptcies this year
What ’s causing drug companies to go bust (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 23, 2019 Category: Pharmaceuticals Source Type: news
FDA places hold on Abeona late-stage study
Abeona Therapeutics announced that the FDA has placed a clinical hold on its planned Phase 3 clinical trial evaluating autologous cell therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 23, 2019 Category: Pharmaceuticals Source Type: news
Akcea ’s top three execs depart
Ionis Pharmaceuticals ' affiliate Akcea Therapeutics has announced the immediate departure of its chief executive officer, president and chief operating officer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 23, 2019 Category: Pharmaceuticals Source Type: news
Pharma's high hopes
Some dreams need to be tethered with a plan (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 21, 2019 Category: Pharmaceuticals Source Type: news
FDA approves expanded use for Merck HIV meds
The FDA has approved Merck ' s supplemental marketing applications for Pifeltro and Delstrigo. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 20, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 9/20/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 20, 2019 Category: Pharmaceuticals Source Type: news
Protestor drops 800-lb. drug spoon on J & J front steps
An activist/artist brought an 800-pound cooking spoon to Johnson and Johnson ' s New Jersey site as a way to protest prescription drugs ' role in the opioid epidemic. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 19, 2019 Category: Pharmaceuticals Source Type: news
Sanofi plans to exit Bangladesh
After 60 years of operating in Bangladesh, Sanofi is reportedly planning to leave the country, putting about 1,000 jobs in jeopardy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 18, 2019 Category: Pharmaceuticals Source Type: news
Novartis stops distribution of Zantac amidst toxin probe
Novartis ’ Sandoz unit has put the brakes on its distribution of a popular heartburn medicine as regulators investigate reports that it could be contaminated. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 18, 2019 Category: Pharmaceuticals Source Type: news
Sanofi partners with Happify Health for digital therapeutics
The two will be developing and studying an app to help manage and improve psychological outcomes in people with multiple sclerosis (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 17, 2019 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Merck Ebola vaccine
The organization granted Breakthrough Therapy Designation to V920 in July 2016 and it now has a target action date of March 14, 2020 (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 17, 2019 Category: Pharmaceuticals Source Type: news
Gene therapies: On the rise
Inside the industry ' s struggle to produce gene therapies on a higher level (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 17, 2019 Category: Pharmaceuticals Source Type: news
Making the case for Indian generic drug manufacturing
In response to the growing regulatory environment, pharmaceutical companies in India continue to strengthen their processes, while improving automation, operating procedures and quality management systems. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
